Serum IgA levels induced by rotavirus natural infection, but not following immunization with the RRV-TV vaccine (Rotashield™), correlate with protection

被引:15
作者
González, R
Franco, M
Sarmiento, L
Romero, M
Schael, IP
机构
[1] Cent Univ Venezuela, Inst Biomed Fuvesin, Secc Invest Enfermedades Entericas Infancia, Minist Salud & Desarrollo Social, Caracas 1010A, Venezuela
[2] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia
[3] Cent Univ Venezuela, Inst Inmunol, Postgrado Inmunol Clin, Minist Salud & Desarrollo Social, Caracas 1010A, Venezuela
[4] Ciudad Hosp Dr Enrique Tejera CHET, Valencia, Estado Carabobo, Venezuela
基金
英国医学研究理事会;
关键词
diarrhea; immune response;
D O I
10.1002/jmv.20404
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To directly compare serum rotavirus specific IgA as a marker of protection in children vaccinated with the RRV-TV (Rotashield (TM)) vaccine and in naturally infected children, we studied preexisting rotavirus IgA antibodies by ELISA assays in these groups of children within the first 5 days after the onset of a diarrhea episode, due or not to rotavirus. In immunized children, rotavirus IgA titers were similar between infected and non-RV infected children. In non-immunized children, the proportion with rotavirus IgA titers was significantly greater in non-RV infected children (58%) than in infected children (31%). Additionally, a titer >= 1:800 was associated with 68% protection. Thus, in this study serum rotavirus IgA showed a good correlation with protection in children pre-exposed to natural infection but not in those immunized with the RRV-TV vaccine. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:608 / 612
页数:5
相关论文
共 26 条
[1]   ROTAVIRUS FECAL IGA ANTIBODY-RESPONSE IN ADULTS CHALLENGED WITH HUMAN ROTAVIRUS [J].
BERNSTEIN, DI ;
ZIEGLER, JM ;
WARD, RL .
JOURNAL OF MEDICAL VIROLOGY, 1986, 20 (04) :297-304
[2]   Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial [J].
Bernstein, DI ;
Sack, DA ;
Rothstein, E ;
Reisinger, K ;
Smith, VE ;
O'Sullivan, D ;
Spriggs, DR ;
Ward, RL .
LANCET, 1999, 354 (9175) :287-290
[3]   Circulating rotavirus-specific antibody-secreting cells (ASCs) predict the presence of rotavirus-specific ASCs in the human small intestinal lamina propria [J].
Brown, KA ;
Kriss, JA ;
Moser, CA ;
Wenner, WJ ;
Offit, PA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1039-1043
[4]   ROLE OF COPROANTIBODY IN CLINICAL-PROTECTION OF CHILDREN DURING REINFECTION WITH ROTAVIRUS [J].
COULSON, BS ;
GRIMWOOD, K ;
HUDSON, IL ;
BARNES, GL ;
BISHOP, RF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) :1678-1684
[5]  
FENG N, 1995, J VIROL, V68, P7766
[6]  
FENG NG, 1995, J VIROL, V69, P3246
[7]   Challenges for rotavirus vaccines [J].
Franco, MA ;
Greenberg, HB .
VIROLOGY, 2001, 281 (02) :153-155
[8]   INTESTINAL AND SERUM IMMUNE-RESPONSE TO A NATURALLY ACQUIRED ROTAVIRUS GASTROENTERITIS IN CHILDREN [J].
HJELT, K ;
GRAUBALLE, PC ;
SCHIOTZ, PO ;
ANDERSEN, L ;
KRASILNIKOFF, PA .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1985, 4 (01) :60-66
[9]   PROTECTIVE EFFECT OF PREEXISTING ROTAVIRUS-SPECIFIC IMMUNOGLOBULIN-A AGAINST NATURALLY ACQUIRED ROTAVIRUS INFECTION IN CHILDREN [J].
HJELT, K ;
GRAUBALLE, PC ;
PAERREGAARD, A ;
NIELSEN, OH ;
KRASILNIKOFF, PA .
JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (01) :39-47
[10]   The role of serum antibodies in the protection against rotavirus disease: An overview [J].
Jiang, BM ;
Gentsch, JR ;
Glass, RI .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (10) :1351-1361